Effective February 22, 2021, Conversion Labs will change its name to Life MD, followed by the official launch of its subscription-based primary care and concierge services offering designed to positively transform all aspects of a patient’s healthcare. Justin Schreiber, company co-founder and CEO, stated, “We see our new name reflecting our evolution and expansion from a branded telemedicine products company into a leading provider of end-to-end concierge telehealth services. Life MD expresses our desire to have a deeper connection to the daily lives of our patients who desire more convenient and on demand access to healthcare, prescriptions and over-the-counter medications.”
Mark Deutsch, President of Deutsch Capital, said, “Conversion Labs is at the forefront of changing the way many consumers receive healthcare. Its disruptive direct-to-consumer technology has enabled the company to grow rapidly. The addressable market is huge and I expect Conversion Labs to be a major competitor within the industry. We are extremely grateful that the company has chosen to work with Deutsch Capital.”
ABOUT CONVERSION LABS
Conversion Labs, Inc. is a leading telemedicine company with a portfolio of online direct-to-consumer brands. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the U.S. To learn more, visit www.LifeMD.com.
ABOUT DEUTSCH CAPITAL
Based in White Plains, NY, Deutsch Capital is a private equity firm that invests in lower middle-market companies across a wide range of industries. Typical investments are in privately owned niche manufacturing, business services and building products companies with sales of $10 million to $100 million. Selectively, the firm also invests in early stage businesses. To learn more, visit www.DeutschCapital.com.